Ignite Creation Date:
2025-12-24 @ 2:42 PM
Ignite Modification Date:
2026-01-12 @ 7:37 AM
Study NCT ID:
NCT04677959
Status:
COMPLETED
Last Update Posted:
2023-03-14
First Post:
2020-12-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-10
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-11
First Submit QC Date:
None
Study First Post Date:
2020-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-14
Results First Submit QC Date:
None
Results First Post Date:
2023-03-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-14
Last Update Post Date:
2023-03-14
Last Update Post Date Type:
ACTUAL